Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stavudine-based multiple agent combinations: initial studies and ongoing comparative trials.

R L Murphy1

  • 1AIDS Treatment Unit, Northwestern University, Chicago, IL 60611, USA. r-murphy@nwu.edu

Antiviral Therapy
|March 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cortical stimulation leads to shortened myelin sheaths and increased axonal branching in spared axons after cervical spinal cord injury.

Glia·2023
Same author

Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Diabetes Mellitus among new tuberculosis patients in Bamako, Mali.

Journal of clinical tuberculosis and other mycobacterial diseases·2019
Same author

Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

Establishing Reference Ranges of Hematological Parameters from Malian Healthy Adults.

Journal of blood & lymph·2018
Same author

Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali.

Epidemiology and infection·2018
Same journal

Safety and efficacy of deltoid intramuscular long-acting cabotegravir and rilpivirine, a case series.

Antiviral therapy·2026
Same journal

Factors associated with immunological non-response in HIV patients receiving antiretroviral therapy in Southeast Asia: A systematic review.

Antiviral therapy·2026
Same journal

Epidemiology and clinical management of cytomegalovirus infection in transplant recipients in Central and Eastern Europe - a physician survey.

Antiviral therapy·2026
Same journal

It's about time: The association between abacavir and cardiovascular disease.

Antiviral therapy·2026
Same journal

Combination antiviral and anti-CMV immunoglobulin therapy for CMV infection: A case-control study.

Antiviral therapy·2026
Same journal

Harnessing SuperNatural database to identify VP35 inhibitors as anti-Ebola drug candidates: A multistage <i>In silico</i> study.

Antiviral therapy·2025
See all related articles

Stavudine (D4T) combinations show strong anti-HIV effects in various patient groups. Ongoing trials will refine first-line HIV treatment options and sequencing strategies.

Area of Science:

  • Infectious Diseases
  • Virology
  • Pharmacology

Background:

  • Stavudine (2',3'-didehydro-2',3'-dideoxythymidine; D4T) is a thymidine nucleoside analogue reverse transcriptase inhibitor (RTI).
  • Initial studies demonstrate potent anti-HIV activity of D4T-based multiple-agent antiretroviral combinations.
  • These combinations are effective in both treatment-naive and treatment-experienced HIV patients.

Purpose of the Study:

  • To evaluate ongoing randomized comparative trials of stavudine-based antiretroviral regimens.
  • To assess different combination strategies including protease inhibitors, triple nucleoside RTI regimens, and non-nucleoside RTIs or hydroxyurea.
  • To inform the definition of optimal first-line HIV treatment and antiretroviral sequencing strategies.

Main Methods:

Related Experiment Videos

  • Review of ongoing randomized comparative trials.
  • Assessment of stavudine-based multiple agent combinations.
  • Analysis of regimens including protease inhibitors (PIs), triple nucleoside RTIs, non-nucleoside RTIs (NNRTIs), and hydroxyurea.

    • Main Results:

    • Stavudine (D4T) combinations exhibit potent anti-HIV effects.
    • Trials are investigating various D4T-based regimens for initial and subsequent HIV therapy.
    • Comparative trials are crucial for defining optimal treatment strategies.

    Conclusions:

    • Stavudine-based antiretroviral combinations are a key component in HIV treatment.
    • Results from ongoing trials will guide future first-line HIV therapy selection.
    • Evidence from these studies will optimize the sequencing of antiretroviral treatment regimens.